Myeloproliferative Neoplasms News

Unprovoked venous thromboembolism appeared associated with a consistently high risk for subsequent cancer diagnosis, according to results of a population-based cohort study.

Immigrants are considerably underserved in terms of health care in the United States.

The Oncology Research Information Exchange Network precision cancer research collaboration has added three new partners to the team: Rutgers Cancer Institute of New Jersey, Morehouse School of Medicine and University of Southern California Norris Comprehensive Cancer Center.

The National Comprehensive Cancer Network awarded research grants to eight investigators.

Factors such as donor age and donor–recipient HLA-match appeared to contribute to long-term survival among patients undergoing unrelated-donor transplantation for hematologic malignancies, according to study results published in Blood.

HemOnc Today’s Chief Medical Editors — Derek Raghavan, MD, PhD, and John Sweetenham, MD — discuss the proliferation of guidelines based on expert opinion rather than high-level data. They also highlight the potential for guidelines to create confusion or anxiety among patients, as well as influence payer decisions.

Douglas Graham, MD, PhD, has been named director of the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta.

Nearly half of women cancer survivors continued to experience symptoms of chemotherapy-induced peripheral neuropathy up to 6 years after treatment, according to research presented at the Cancer Survivorship Symposium.

There are approximately 14.5 million cancer survivors in the United States, according to the American Cancer Society.

ORLANDO — Patricia Kropf, MD, discusses study results she presented at the ASH Annual Meeting and Exposition that showed the combination of arsenic and decitabine induced improved response rates in patients with myelodysplastic syndrome and acute myeloid leukemia.